Eastman Chemical
EMNNYSEOther · Plastic Materials, Synth Resins & Nonvulcan Elastomers · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $8.75B | $9.38B | $9.21B | $10.58B | $10.48B | $8.47B |
| Operating income | — | — | — | — | — | — |
| Net income | $474.0M | $905.0M | $894.0M | $793.0M | $857.0M | $478.0M |
| Total assets | $14.86B | $15.21B | $14.63B | $14.67B | $15.52B | $16.08B |
| Total liabilities | $8.82B | $9.36B | $9.10B | $9.43B | $9.73B | $9.97B |
| Equity | $5.96B | $5.78B | $5.46B | $5.15B | $5.70B | $6.02B |
| EPS (diluted) | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 |
| Shares out. | 114.1M | 115.2M | 117.3M | 118.8M | 129.0M | 135.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 5.4%
- Return on equity
- 8.0%
- Return on assets
- 3.2%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 59.4%
- Debt / equity
- 1.48×
- Book value / share
- $52.24
- Revenue growth (YoY)
- −6.7%
- Net income growth (YoY)
- −47.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −3.3%clean
- Beneish M-Score
- -2.58normal
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 2 good- Revenue declined year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Blackrock, Inc.Passive (13G)Apr 24, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Capital Research Global InvestorsPassive (13G)Aug 13, 2025
- Franklin Resources IncPassive (13G)Aug 5, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Slager Donald WDirector | May 7, 2026 | Grant | 1,628 | $0.00 |
| Holder Julie FasoneDirector | May 7, 2026 | Grant | 1,628 | $0.00 |
| Hornbaker Renee JDirector | May 7, 2026 | Grant | 1,628 | $0.00 |
| Obrien James J /KyDirector | May 7, 2026 | Grant | 1,628 | $0.00 |
| Butler Eric LDirector | May 7, 2026 | Grant | 1,628 | $0.00 |
| Haynesworth Linnie MDirector | May 7, 2026 | Grant | 1,628 | $0.00 |
| Holt Adrian JamesOfficer — SVP, Chf HR Ofcr | May 5, 2026 | Sell | 1,709 | $77.05 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 5.1M | 4.2 | +7.8% |
| Apr 30, 2026 | 4.7M | 4.0 | -7.8% |
| Apr 15, 2026 | 5.1M | 3.7 | -4.3% |
| Mar 31, 2026 | 5.3M | 2.8 | +18.6% |
| Mar 13, 2026 | 4.5M | 2.5 | -11.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 12, 2026
- Results of operationsApr 30, 2026
- Entered a material agreement · Other material eventFeb 20, 2026
- Results of operationsJan 29, 2026
- Results of operationsNov 3, 2025
- Director / officer changeOct 9, 2025
- Results of operationsJul 31, 2025
- Director / officer change · Regulation FD disclosureJun 27, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SD2025 CONFLICT MINERALS REPORTMay 29, 2026
- 8-K8-K VOTING RESULTSMay 12, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 11, 2026
- 4FORM 4May 7, 2026
- 144May 5, 2026
- 10-QMay 1, 2026
Corporate family
Spin-offs from Eastman Chemical (1)
- EASTMAN COwithdrawnNov 13, 2001details
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.